Inflammation in the heart causes irreversible cardiac tissue damage. Unlike other organs, a damaged heart cannot regenerate and can lead to serious health problems. The adult heart contains distinct macrophage subsets with different functions. We sought to identify a heart macrophage subset highly specialized in tissue protection. We fully landscaped the immune profile of human pericardial fluid cells using unbiased single cell level analysis techniques, mass cytometry (CyTOF) and single cell RNA sequencing (scRNA-seq). Given the well-characterized phenotype and cutting-edge bioinformatic analysis, we predict that Gata6-expressing macrophages in the pericardial fluid play a heart protective role through tissue repair, efferocytosis, phagocytosis and immune regulation. The goal of this study is to focus on Gata6+ pericardial macrophages for in-depth studies of their role in inflammatory and ischemic heart diseases and to identify their cardioprotective mechanisms.
In Aim 1, we will comprehensively characterize the immune phenotype and function of the pericardial effusion cells including Gata6+ macrophages in patients with or without heart diseases. In our preliminary study, we found a decrease of Gata6+ macrophages and an increase of memory T cells in the pericardial fluid of ischemic heart disease and pericarditis patients. We plan to collect 80 pericardial fluid samples from ischemic heart disease, perimyocarditis and pericarditis patients. We will immune profile the human pericardial fluid cells using CyTOF and scRNA-seq. We will also determine if the reduction of Gata6+ pericardial macrophages reflects a more severe disease in these patients by analyzing clinical outcomes.
Aim 2 will utilize state-of-the-art macrophage fate-mapping techniques in the Coxsackievirus B3 (CVB3)-induced myocarditis mouse model to determine the origin and fate of GATA6+ pericardial macrophages in nave and viral conditions. The replenishment of GATA6+ pericardial macrophages by blood circulating monocytes will be tested too.
Aim 3 will address the mechanism how Gata6+ pericardial macrophages protect the heart from inflammatory damages using in vivo and in vitro experimental models. Our preliminary study showed that a selective depletion of Gata6+ pericardial macrophages worsened myocarditis in mice. We will profile the transcriptomes expressed by cardiac immune cells and non-hematopoietic stromal cells in Gata6+ macrophage-depleted mice with myocarditis. To prove the protective role of Gata6+ macrophages, we will test their efferocytosis and anti-inflammatory activity using in vitro assays. In addition, we will determine the crosstalk between Gata6+ macrophages and cardiac fibroblasts inhibiting pro-inflammatory monocyte infiltration. This study will reveal (1) a previously unidentified heart protective macrophage subset in the pericardial cavity, (2) the mechanisms of their tissue protective function, and (3) the potential of Gata6+ pericardial macrophages as a target for new diagnostic and therapeutic strategies in inflammatory cardiac diseases.

Public Health Relevance

We found that pericardial cavity contains macrophages that are able to traffic to the myocardium quickly after a myocardial infarction. We propose to investigate if these macrophages play a beneficial role in restoring cardiac homeostasis after myocardial infarction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL118183-06A1
Application #
10057920
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Adhikari, Bishow B
Project Start
2014-02-01
Project End
2024-06-30
Budget Start
2020-09-15
Budget End
2021-06-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Chen, Guobao; Bracamonte-Baran, William; Diny, Nicola L et al. (2018) Sca-1+ cardiac fibroblasts promote development of heart failure. Eur J Immunol 48:1522-1538
Cihakova, Daniela (2018) Interleukin-10 stiffens the heart. J Exp Med 215:379-381
Ong, SuFey; Rose, Noel R; ?iháková, Daniela (2017) Natural killer cells in inflammatory heart disease. Clin Immunol 175:26-33
Fontes, Jillian A; Barin, Jobert G; Talor, Monica V et al. (2017) Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response. Immun Inflamm Dis 5:163-176
Diny, Nicola L; Baldeviano, G Christian; Talor, Monica V et al. (2017) Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. J Exp Med 214:943-957
Diny, Nicola L; Rose, Noel R; ?iháková, Daniela (2017) Eosinophils in Autoimmune Diseases. Front Immunol 8:484
Bracamonte-Baran, William; ?iháková, Daniela (2017) Cardiac Autoimmunity: Myocarditis. Adv Exp Med Biol 1003:187-221
Barin, Jobert G; Talor, Monica V; Diny, Nicola L et al. (2017) Regulation of autoimmune myocarditis by host responses to the microbiome. Exp Mol Pathol 103:141-152
Diny, Nicola L; Hou, Xuezhou; Barin, Jobert G et al. (2016) Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur J Immunol 46:2749-2760
Barin, Jobert G; Talor, Monica V; Schaub, Julie A et al. (2016) Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol 186:2337-52

Showing the most recent 10 out of 14 publications